HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christine Mölzer Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2018Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: Implications for improved metabolic health.
4/2017Bilirubin Decreases Macrophage Cholesterol Efflux and ATP-Binding Cassette Transporter A1 Protein Expression.
7/2015Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases.
10/2013Anti-genotoxic potential of bilirubin in vivo: damage to DNA in hyperbilirubinemic human and animal models.
2/2013In vitro DNA-damaging effects of intestinal and related tetrapyrroles in human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christine Mölzer Research Topics

Disease

7Gilbert Disease
12/2021 - 09/2013
5Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 02/2013
3Uveitis
01/2021 - 01/2020
3Inflammation (Inflammations)
01/2020 - 09/2013
3Neoplasms (Cancer)
07/2015 - 02/2013
2Type 2 Diabetes Mellitus (MODY)
12/2021 - 07/2015
2Fibrosis (Cirrhosis)
01/2019 - 01/2019
2Obesity
01/2018 - 01/2016
2Hyperbilirubinemia
04/2017 - 01/2017
1Metabolic Diseases (Metabolic Disease)
12/2021
1Dyslipidemias (Dyslipidemia)
12/2021
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Intermediate Uveitis (Chronic Cyclitis)
01/2020
1Posterior Uveitis
01/2020
1Lymphopenia (Lymphocytopenia)
01/2020
1Wounds and Injuries (Trauma)
01/2019
1Overweight
01/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2015
1Disease Resistance
07/2015
1Chronic Disease (Chronic Diseases)
07/2015
1Noncommunicable Diseases
09/2013

Drug/Important Bio-Agent (IBA)

8BilirubinIBA
12/2021 - 02/2013
4Heme (Haem)IBA
01/2021 - 09/2013
2LipidsIBA
12/2021 - 09/2021
2Biomarkers (Surrogate Marker)IBA
09/2021 - 07/2015
2Retinaldehyde (Retinal)IBA
01/2020 - 01/2020
2HydrogelsIBA
01/2019 - 01/2019
2TetrapyrrolesIBA
07/2015 - 02/2013
2Bile Pigments (Bilin)IBA
07/2015 - 10/2013
2DNA (Deoxyribonucleic Acid)IBA
10/2013 - 02/2013
1Proteins (Proteins, Gene)FDA Link
09/2021
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2021
1Antimutagenic Agents (Antimutagens)IBA
01/2021
1AntigensIBA
01/2020
1hen egg lysozymeIBA
01/2020
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2020
1interstitial retinol-binding proteinIBA
01/2020
1Keratin-12 (Keratin 12)IBA
01/2019
1TenascinIBA
01/2019
1N-hydroxysuccinimideIBA
01/2019
1CholesterolIBA
04/2017
1LDL CholesterolIBA
04/2017
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2016
1Adenosine Triphosphate (ATP)IBA
01/2016
1AntioxidantsIBA
10/2013
1Interleukin-6 (Interleukin 6)IBA
09/2013
1Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
09/2013
1IronIBA
09/2013
1protoporphyrin IXIBA
02/2013
1stercobilinIBA
02/2013
1UrobilinIBA
02/2013